| 2026 | 2025 | 2024 | 2021 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 196,2 M € | +6.5% | 184,2 M € | +67.2% | 110,1 M € | +24.1% | 88,8 M € | +14.2% | 77,8 M € | +39.4% | 55,8 M € | -3.4% | 57,7 M € | +51.0% | 38,2 M € | +12.4% | 34,0 M € | +20.1% | 28,3 M € | +4.6% | 27,1 M € | -36.1% | 42,4 M € | -3.7% | 44,0 M € | +2.4% | 42,9 M € | +19.1% | 36,0 M € | +4.3% | 34,6 M € | +58.1% | 21,9 M € | +82.1% | 12,0 M € | |
| EBITDA | 1,6 M € | +7.5% | 1,5 M € | +98.8% | 754,0 k € | +147.9% | -1,6 M € | -347.4% | 636,1 k € | +70.6% | 372,9 k € | +2.6% | 363,2 k € | +28.6% | 282,5 k € | +36.2% | 207,4 k € | +425.3% | -63,8 k € | -167.2% | 94,9 k € | -78.0% | 432,2 k € | +64.6% | 262,5 k € | +4.3% | 251,7 k € | +139.3% | 105,2 k € | -36.6% | 165,9 k € | +65.1% | 100,5 k € | +174.8% | -134,3 k € | |
| Operating profit | 1,0 M € | +6.7% | 953,0 k € | +73.7% | 548,6 k € | +127.3% | -2,0 M € | -541.2% | 455,7 k € | +132.8% | 195,7 k € | +49.7% | 130,7 k € | +17.8% | 111,0 k € | +430.3% | 20,9 k € | +115.0% | -139,3 k € | +30.3% | -199,8 k € | -871.1% | 25,9 k € | -44.9% | 47,0 k € | -48.1% | 90,5 k € | +1194.2% | -8,3 k € | -108.2% | 100,9 k € | -8.3% | 110,0 k € | +455.9% | -30,9 k € | |
| Profit/loss | 1,2 M € | +3.4% | 1,2 M € | +114.6% | 549,2 k € | +125.7% | -2,1 M € | -653.1% | 386,8 k € | +137.6% | 162,8 k € | +91.4% | 85,0 k € | -41.7% | 145,9 k € | +138.7% | 61,2 k € | +179.9% | -76,6 k € | +50.2% | -153,6 k € | -474.4% | 41,0 k € | +179.1% | -51,9 k € | -149.2% | 105,6 k € | +1823.5% | -6,1 k € | +90.1% | -61,8 k € | -234.8% | 45,9 k € | +140.9% | -112,2 k € | |
| Equity | 334,4 k € | +137.8% | -884,4 k € | +57.1% | -2,1 M € | -70.5% | -1,2 M € | -229.2% | 936,1 k € | +68.3% | 556,1 k € | +38.9% | 400,3 k € | +23.5% | 324,1 k € | +72.3% | 188,1 k € | +28.3% | 146,6 k € | -41.2% | 249,5 k € | -42.8% | 436,1 k € | +1.7% | 428,8 k € | -15.8% | 509,4 k € | +86.3% | 273,4 k € | -2.2% | 279,5 k € | -18.1% | 341,4 k € | +15.5% | 295,5 k € | |
| Total assets | 29,1 M € | +18.4% | 24,6 M € | +5.8% | 23,2 M € | -18.0% | 28,4 M € | +28.4% | 22,1 M € | +51.3% | 14,6 M € | +21.1% | 12,0 M € | +72.9% | 7,0 M € | +0.3% | 7,0 M € | +13.6% | 6,1 M € | +26.5% | 4,8 M € | -32.2% | 7,1 M € | -11.9% | 8,1 M € | -12.5% | 9,3 M € | +28.6% | 7,2 M € | +40.9% | 5,1 M € | -1.3% | 5,2 M € | +127.3% | 2,3 M € | |
| Cash | 12,3 k € | — | 435,4 k € | +517.4% | 70,5 k € | -44.8% | 127,7 k € | +169.8% | 47,3 k € | -68.6% | 151,0 k € | -88.9% | 1,4 M € | -24.7% | 1,8 M € | +105.1% | 877,9 k € | +25.1% | 701,6 k € | -28.8% | 985,3 k € | +34.5% | 732,7 k € | +3.8% | 706,2 k € | -7.5% | 763,2 k € | +762.7% | 88,5 k € | -90.7% | 953,1 k € | +2608.4% | 35,2 k € | |||
| Debts | 28,6 M € | +12.8% | 25,3 M € | +0.2% | 25,3 M € | -14.4% | 29,6 M € | +39.8% | 21,1 M € | +50.7% | 14,0 M € | +20.5% | 11,6 M € | +75.3% | 6,6 M € | -1.8% | 6,8 M € | +13.2% | 6,0 M € | +30.1% | 4,6 M € | -31.5% | 6,7 M € | -12.6% | 7,7 M € | -12.3% | 8,7 M € | +27.1% | 6,9 M € | +47.8% | 4,7 M € | -2.0% | 4,8 M € | +147.6% | 1,9 M € | |
| Staff | 49,2 | 42,5 | 37,5 | 42,9 | 38,3 | 32,3 | 31,8 | 29,5 | 24,7 | 20,5 | 21,4 | 23,9 | 24,9 | 16,9 | 12,3 | 11,3 | 5,8 | 4,3 | ||||||||||||||||||
Public limited company · La Louvière · incorporated on 07/03/1958 · 49,2 ETP
Public limited company profitable but thinly capitalised. Cash position declining (-97.2%).
Solid counterparty for a standard engagement.
Cophana is a Public limited company incorporated in 1958. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in La Louvière. It employs on average 49,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette